DeepMed Research

Royal Marsden NHS Foundation Trust

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website: http://www.royalmarsden.nhs.uk

Clinical Trials

Validation of a Nutrition Screening Tool

Completed

Conditions: Adenocarcinoma of the Gastroesophageal Junction
Cervical Cancer
Endometrial Cancer
Esophageal Cancer
Fallopian Tube Cancer
Gastric Cancer
Ovarian Cancer
Sarcoma
Vaginal Cancer
Vulvar Cancer

First Posted Date: 2013-05-13

Last Posted Date: 2013-05-13

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 128

Registration Number: NCT01851928

Locations: 🇬🇧
Royal Marsden Hospital NHS Foundation Trust, London, London .., United Kingdom

Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours

Phase 2

Conditions: Squamous Cell Carcinoma of the Lung
Gastric Cancer
Oesophageal Cancer
Breast Cancer

Interventions: Drug: AZD 4547

First Posted Date: 2013-02-21

Last Posted Date: 2013-03-15

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 48

Registration Number: NCT01795768

Locations: 🇬🇧
Royal Marsden NHS Foundation Trust, London and Surrey, Surrey, United Kingdom

CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study

Phase 2

Conditions: Peripheral T-cell Lymphoma NOS
Angioimmunoblastic T-cell Lymphoma
Anaplastic Large Cell Lymphoma, ALK-Negative
Hepatosplenic Gamma/ Delta T-cell Lymphoma
Enteropathy-Associated T-Cell Lymphoma

Interventions: Drug: Gemcitabine
Drug: Cyclophosphamide
Drug: Doxorubicin
Drug: methylprednisolone
Drug: Vincristine
Drug: Cisplatin
Drug: Prednisolone

First Posted Date: 2012-11-01

Last Posted Date: 2018-03-15

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 87

Registration Number: NCT01719835

Locations: 🇬🇧
Royal Marsden NHS Foundation Trust - London and Surrey, London, United Kingdom

Pain: Screen and Treat

Phase 3

Conditions: Pain
Head and Neck Cancer

Interventions: Other: Intervention

First Posted Date: 2012-10-30

Last Posted Date: 2012-10-30

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 156

Registration Number: NCT01716780

Locations: 🇬🇧
Royal Marsden Hospital, London, United Kingdom

Prostate Advances in Comparative Evidence

Phase 3

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Radiation: Conventionally Fractionated Prostate Radiotherapy
Procedure: Prostatectomy
Radiation: Prostate SBRT

First Posted Date: 2012-04-24

Last Posted Date: 2024-01-19

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 2205

Registration Number: NCT01584258

Locations: 🇨🇦
Hôpital Charles-LeMoyne, Montréal, Quebec, Canada
🇬🇧
Royal Marsden NHS Foundation Trust, London, United Kingdom
🇬🇧
St Bartholomew's Hospital, London, United Kingdom

and more 64 locations

A Survivorship Care Plan for Gynaecological Cancer Patients

Completed

Conditions: Esophageal Cancer
Adenocarcinoma of the Gastroesophageal Junction
Cervical Cancer
Ovarian Cancer
Fallopian Tube Cancer
Gastric Cancer
Sarcoma
Vulvar Cancer
Endometrial Cancer
Vaginal Cancer

First Posted Date: 2012-04-23

Last Posted Date: 2017-11-24

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 150

Registration Number: NCT01582906

Locations: 🇬🇧
Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom

Evaluation of the Hospital2Home Palliative Care Service for Patients With Advanced Progressive Lung Disease

Phase 2

Conditions: Lung Disease

Interventions: Other: The Hospital2Home Service

First Posted Date: 2011-10-12

Last Posted Date: 2011-12-08

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 52

Registration Number: NCT01450644

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom
🇬🇧
The Royal Brompton NHS Foundation Trust, London, United Kingdom

Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study)

Phase 2

Completed

Conditions: Cancer
Peripheral Neuropathy

Interventions: Drug: Placebo
Drug: Ethosuximide

First Posted Date: 2011-01-17

Last Posted Date: 2016-05-26

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 15

Registration Number: NCT01278004

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom
🇬🇧
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

Reflexology or Aromatherapy Massage in Relieving Symptoms in Patients With Cancer

Not Applicable

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Pain
Psychosocial Effects of Cancer and Its Treatment

First Posted Date: 2010-10-08

Last Posted Date: 2016-11-01

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 100

Registration Number: NCT01217424

Locations: 🇬🇧
Royal Marsden - London, London, England, United Kingdom

Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer

Completed

Conditions: Sarcoma
Adenocarcinoma of the Gastroesophageal Junction
Esophageal Cancer
Fallopian Tube Cancer
Gastric Cancer
Vulvar Cancer
Endometrial Cancer
Vaginal Cancer
Cervical Cancer
Ovarian Cancer

First Posted Date: 2010-10-07

Last Posted Date: 2016-11-01

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 33

Registration Number: NCT01216813

Locations: 🇬🇧
Royal Marsden - London, London, England, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy